Webinar: Innovative Registry Approaches

On Sept. 15, The Pew Charitable Trusts hosted a webinar highlighting a Pew-funded Avalere report, Innovative Approaches to Accessing, Extracting and Aggregating Electronic Health Data: Experiences From Five US Medical Device Registries.

The webinar examined key challenges that registries face in collecting critical data on the performance of medical devices, as well as innovative ways they have addressed these challenges.

Featured speakers included:

  • Kathleen Hewitt, vice president
    American College of Cardiology: National Cardiovascular Data Registry CathPCI Registry
  • William L. Rich III, M.D., medical director of heath policy
    American Academy of Ophthalmology: IRIS Registry
  • Kristi Mitchell, M.P.H., senior vice president
    Avalere Health LLC
  • Josh Rising, M.D., director, healthcare programs
    The Pew Charitable Trusts
  • Angela Franklin, J.D., senior officer, drugs and medical devices
    The Pew Charitable Trusts

National Homeownership Month


37 Researchers Working to Transform Biomedical Science

Quick View

Biomedical researchers are on the front lines of scientific innovation. From responding to global pandemics to pioneering lifesaving cancer treatments, these researchers push past scientific boundaries to solve pressing health challenges. For nearly 40 years, The Pew Charitable Trusts has supported more than 1,000 early-career biomedical scientists committed to this discovery.

Composite image of modern city network communication concept

Learn the Basics of Broadband from Our Limited Series

Sign up for our four-week email course on Broadband Basics

Quick View

How does broadband internet reach our homes, phones, and tablets? What kind of infrastructure connects us all together? What are the major barriers to broadband access for American communities?

Pills illustration
Pills illustration

What Is Antibiotic Resistance—and How Can We Fight It?

Sign up for our four-week email series The Race Against Resistance.

Quick View

Antibiotic-resistant bacteria, also known as “superbugs,” are a major threat to modern medicine. But how does resistance work, and what can we do to slow the spread? Read personal stories, expert accounts, and more for the answers to those questions in our four-week email series: Slowing Superbugs.